225 related articles for article (PubMed ID: 30321504)
1. CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.
Huang F; Wang M; Liu R; Wang JZ; Schadt E; Haroutunian V; Katsel P; Zhang B; Wang X
Alzheimers Dement; 2019 Feb; 15(2):217-231. PubMed ID: 30321504
[TBL] [Abstract][Full Text] [Related]
2. Characterization of null and hypomorphic alleles of the Drosophila l(2)dtl/cdt2 gene: Larval lethality and male fertility.
Sloan RS; Swanson CI; Gavilano L; Smith KN; Malek PY; Snow-Smith M; Duronio RJ; Key SC
Fly (Austin); 2012; 6(3):173-83. PubMed ID: 22722696
[TBL] [Abstract][Full Text] [Related]
3. Emerging Roles of Inhibitor of Differentiation-1 in Alzheimer's Disease: Cell Cycle Reentry and Beyond.
Chen SD; Yang JL; Lin YC; Chao AC; Yang DI
Cells; 2020 Jul; 9(7):. PubMed ID: 32708313
[TBL] [Abstract][Full Text] [Related]
4. miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.
Singh G; Sharma SK; Singh SK
BMC Cancer; 2022 Jul; 22(1):777. PubMed ID: 35840896
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.
Benamar M; Guessous F; Du K; Corbett P; Obeid J; Gioeli D; Slingluff CL; Abbas T
EBioMedicine; 2016 Aug; 10():85-100. PubMed ID: 27333051
[TBL] [Abstract][Full Text] [Related]
6. FOXG1 as a Potential Therapeutic Target for Alzheimer's Disease with a Particular Focus on Cell Cycle Regulation.
Wang J; Ma SF; Yun Q; Liu WJ; Zhai HR; Shi HZ; Xie LG; Qian JJ; Zhao CJ; Zhang WN
J Alzheimers Dis; 2022; 86(3):1255-1273. PubMed ID: 35180113
[TBL] [Abstract][Full Text] [Related]
7. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease.
Zekanowski C; Wojda U
Acta Neurobiol Exp (Wars); 2009; 69(2):232-53. PubMed ID: 19593337
[TBL] [Abstract][Full Text] [Related]
8. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.
Absalon S; Kochanek DM; Raghavan V; Krichevsky AM
J Neurosci; 2013 Sep; 33(37):14645-59. PubMed ID: 24027266
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J
Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945
[TBL] [Abstract][Full Text] [Related]
10. Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients.
Hradek AC; Lee HP; Siedlak SL; Torres SL; Jung W; Han AH; Lee HG
J Alzheimers Dis; 2015; 43(1):57-65. PubMed ID: 25061053
[TBL] [Abstract][Full Text] [Related]
11. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
Lee HG; Casadesus G; Zhu X; Castellani RJ; McShea A; Perry G; Petersen RB; Bajic V; Smith MA
Neurochem Int; 2009 Feb; 54(2):84-8. PubMed ID: 19114068
[TBL] [Abstract][Full Text] [Related]
13. Role of tau protein in Alzheimer's disease: The prime pathological player.
Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
[TBL] [Abstract][Full Text] [Related]
14. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
15. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
Wang WZ; Li MW; Chen Y; Liu LY; Xu Y; Xia ZH; Yu Y; Wang XD; Chen W; Zhang F; Xu XY; Gao YF; Zhang JG; Qin SC; Wang H
J Alzheimers Dis; 2021; 82(4):1635-1649. PubMed ID: 34219730
[TBL] [Abstract][Full Text] [Related]
16. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
[TBL] [Abstract][Full Text] [Related]
17. Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells.
Ueki T; Nishidate T; Park JH; Lin ML; Shimo A; Hirata K; Nakamura Y; Katagiri T
Oncogene; 2008 Sep; 27(43):5672-83. PubMed ID: 18542055
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease.
Zhao ZB; Wu L; Xiong R; Wang LL; Zhang B; Wang C; Li H; Liang L; Chen SD
Neuroscience; 2014 Sep; 275():232-7. PubMed ID: 24950120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
